Mirum Pharmaceuticals, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Mirum Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $329.09M.
- Mirum Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $259.95M.
- Mirum Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $17.38M, a 147.00% increase year-over-year.
- Mirum Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $7.04M, a 84.24% decline year-over-year.
- Mirum Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2021 was $7.04M.
- Mirum Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2019 was $67.20M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $329.09M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $259.95M 10-Q · filed 2026-08-05 | |
| 2022-03-31 | $17.38M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $7.04M 10-K · filed 2022-03-09 | |
| 2021-03-31 | $7.04M 10-Q · filed 2022-11-09 | |
| 2020-03-31 | $44.66M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $67.20M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $67.20M 10-Q · filed 2020-11-12 | |
| 2018-09-30 | $1.00K 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |